tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Skye Bioscience, Inc. (SKYE)
NASDAQ:SKYE
US Market
SKYE
Skye Bioscience
RESEARCH TOOLSreports

Skye Bioscience (SKYE) Stock News & Sentiment

Compare
936 Followers
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/14/25
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/14/25
3d ago
CLB
VTI
What Investors Can Learn from the Skye Bioscience Securities Fraud Allegations: A Risk Assessment Guide
Premium
Class Action
What Investors Can Learn from the Skye Bioscience Securities Fraud Allegations: A Risk Assessment Guide
7d ago
SKYE
VTI ETF Daily Update — 1/7/25
Premium
Market News
VTI ETF Daily Update — 1/7/25
10d ago
RPT
VTI
Skye Bioscience: ENHANZE Partnership Unlocks Nimacimab Dosing, De-Risks Phase 2b Path and Supports Buy Rating
Premium
Ratings
Skye Bioscience: ENHANZE Partnership Unlocks Nimacimab Dosing, De-Risks Phase 2b Path and Supports Buy Rating
11d ago
SKYE
Skye Bioscience Collaborates with Halozyme on Nimacimab Delivery
Premium
Company Announcements
Skye Bioscience Collaborates with Halozyme on Nimacimab Delivery
24d ago
8K
SKYE
Skye Bioscience Faces Lawsuit Over Misleading Claims
Premium
Class Action
Skye Bioscience Faces Lawsuit Over Misleading Claims
2M ago
SKYE
Promising Adjunct Potential of Skye Bioscience’s Nimacimab Reinforces Buy Rating
Premium
Ratings
Promising Adjunct Potential of Skye Bioscience’s Nimacimab Reinforces Buy Rating
2M ago
SKYE
More SKYE News >

SKYE News on the Web

Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/14/25
TipRanks News
Neutral
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying
rttnews
Neutral
Skye Bioscience Faces Lawsuit Over Misleading Claims
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Skye Bioscience (SKYE)
TipRanks News
Neutral
Oppenheimer Sticks to Their Buy Rating for Skye Bioscience (SKYE)
TipRanks News
Neutral
Why Skye Bioscience, Inc.’s (SKYE) Stock Is Down 7.80%
AAII
Neutral
Why Skye Bioscience, Inc.’s (SKYE) Stock Is Up 5.72%
AAII
Neutral
SKYE Stock Plunges 60% as Obesity Candidate Misses Key Phase II Goal
Zacks
Neutral

News Score - Last 7 Days

Neutral
SKYE
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week59%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SKYE’s Media Buzz Sentiment?
1 articles about SKYE were published this week. In an average week, 1 articles are published.
    What is SKYE’s weekly average amount of articles?
    In an average week, 1 articles about SKYE are published.
      What is SKYE’s News Sentiment?
      59% of articles about SKYE were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        CAHCardinal Health
        ALKSAlkermes
        WSTWest Pharmaceutical Services
        AGENAgenus
        PENPenumbra
        Showing the stocks with the most bullish news sentiment over the past week